Early to mid-November was been a great time to be invested in Aurora Cannabis (NYSE:ACB). After a spectacular upside move in ACB stock on Nov. 6, it looks like the share price was set to go even higher.


Source: Shutterstock
Some folks might think that ACB stock, and pot stocks generally, are surging because drugmakers Pfizer (NYSE:PFE) and Germany-based BioNTech SE (NASDAQ:BNTX) announced “success” in the first interim analysis from a Phase 3 study of their novel coronavirus vaccine candidate, BNT162b2.

That’s undoubtedly good news, but it’s not necessarily the main reason for the bullish sentiment surrounding marijuana stocks like ACB. After all, people haven’t typically been waiting for a Covid-19 vaccine in order to use cannabis products.
In actuality, the chief driver of ultra-bullish sentiment with ACB stock may have a political aspect. And the problem with politics is that it can be ugly, unpredictable and, in the final analysis, difficult to base…
Original Author Link click here to read complete story..
Source link